4 reports

Real Life Study (VISTA) GDCT## NCT##, C## Toxicology Chemotherapy Induced Neutropenia Ongoing, recruiting Phase IV Observational filgrastim Pfizer Inc Hospira Inc ## Oct 2014 ## Oct 2016 ## ## Granulocyte Colony Stimulating Factor Receptor (CD## or GCSFR or CSF##R) Agonis

  • Chemotherapy
  • Filgrastim
  • Therapy
  • World
  • Product Initiative

filgrastim ## cyclophosphamide ## docetaxel (piperacillin sodium + tazobactam sodium) (piperacillin + tazobactam) Total Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2017 2017 trials are taken as of August 2017 ##

  • Clinical Trial
  • Filgrastim
  • World
  • Product Initiative
  • Amgen Inc.

-approved Drug Neupogen (Amgen) GDCT## NCT##, ZIN-FIL-##; C## Hematological Disorders Neutropenia Completed Phase I Interventional filgrastim Pfizer Inc.

  • Blood Disease
  • Filgrastim
  • World
  • Product Initiative
  • Amgen Inc.

Compared to Granulokine Produced by Produtos Roche Químicos e Farmaceuticos S/ A Evaluation of Pharmacokinetic and Pharmacodynamic Parameters of Filgrastim (G- CSF)Produced by Blausiegel Industria e Comrcio Ltda.

  • Blood Disease
  • Blood Supply
  • Filgrastim
  • World
  • Product Initiative